Targeting pathological remodeling: Concepts of cardioprotection and reparation

Circulation

Volumn 102, Issue 12, 2000, Pages 1342-1345

  Weber, Karl T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Angiotensin; Collagen; Editorials; Fibrosis; Hypertension; Hypertrophy

Indexed keywords

ADAPTATION; EDITORIAL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE PERFORMANCE; HUMAN; HYPERTENSION; PRIORITY JOURNAL;

EID: 0034687077     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.12.1342     Document Type: Editorial

References (20)

1. Cardiac interstitium in health and disease: The fibrillar collagen network
2. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system
3. Left ventricular hypertrophy: Relation of structure to diastolic function in hypertension
4. Vascular remodeling of resistance vessels: Can we define this?
5. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
6. Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed
7. Angiotensin II and connective tissue: Homeostasis and reciprocal regulation
8. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade
9. Early induction of transforming growth factor-β via angiotensin II type I receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats
10. 2 receptor knockout mice
11. The effects of acutely increased ventricular cavity pressure on intrinsic myocardial connective tissue
12. Left ventricular rupture threshold during the healing phase after myocardial infarction in the dog
13. Impaired diastolic function and coronary reserve in genetic hypertension: Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries
14. Advanced hypertensive heart disease in spontaneously hypertensive rats: Lisinopril-mediated regression of myocardial fibrosis
15. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease
16. In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans
17. Echocardiographic patterns of myocardial fibrosis in hypertensive patients: Endomyocardial biopsy versus ultrasonic tissue characterization
18. Treatment with lisinopril normalizes serum concentrations of procollagen type III amino-terminal peptide in patients with essential hypertension
19. Increased serum concentrations of procollagen peptides in essential hypertension: Relation to cardiac alterations
20. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease